Literature DB >> 12679238

Functional effects of antipsychotic drugs: comparing clozapine with haloperidol.

Adrienne C Lahti1, Henry H Holcomb, Martin A Weiler, Deborah R Medoff, Carol A Tamminga.   

Abstract

BACKGROUND: Using positron emission tomography (PET) with (15)O water, we compared regional cerebral blood flow (rCBF) patterns induced by clozapine or haloperidol in individuals with schizophrenia. Based on the known clinical characteristics of each drug, we hypothesized that brain regions where the drugs show similar rCBF patterns are among those mediating their antipsychotic actions; whereas, regions where the drugs produce different rCBF patterns are among those mediating their different drug actions, namely, haloperidol's motor side effects or clozapine's unique therapeutic action.
METHODS: Persons with schizophrenia were scanned using PET with (15)O water, first after withdrawal of all psychotropic medication (n = 6), then again after treatment with therapeutic doses of haloperidol (n = 5) or clozapine (n = 5).
RESULTS: Both drugs increased rCBF in the ventral striatum and decreased rCBF in hippocampus and ventrolateral frontal cortex. The rCBF increase associated with haloperidol was greater than that with clozapine in the dorsal and ventral striatum; the rCBF increase with clozapine was greater than that with haloperidol in cortical regions, including anterior cingulate and dorsolateral frontal cortex.
CONCLUSIONS: These data suggest that the rCBF increase in ventral striatum and/or the decrease in hippocampus and/or ventrolateral frontal cortex mediate a common component of antipsychotic action of these drugs. The increased rCBF in dorsal striatum by haloperidol could well be associated with its prominent motor side effects, whereas the increased rCBF in the anterior cingulate or dorsolateral frontal cortex may mediate the superior antipsychotic action of clozapine. The proposals based on these preliminary observations require further study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679238     DOI: 10.1016/s0006-3223(02)01602-5

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  54 in total

1.  Differential effects of clozapine and haloperidol on interval timing in the supraseconds range.

Authors:  Christopher J MacDonald; Warren H Meck
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

2.  Cerebral blood flow in striatal regions is associated with apathy in patients with schizophrenia.

Authors:  Karoline Schneider; Lars Michels; Matthias N Hartmann-Riemer; Achim Burrer; Philippe N Tobler; Philipp Stämpfli; Matthias Kirschner; Erich Seifritz; Stefan Kaiser
Journal:  J Psychiatry Neurosci       Date:  2019-03-01       Impact factor: 6.186

3.  Effects of amisulpride on human resting cerebral perfusion.

Authors:  Roberto Viviani; Heiko Graf; Maike Wiegers; Birgit Abler
Journal:  Psychopharmacology (Berl)       Date:  2013-04-13       Impact factor: 4.530

Review 4.  Use of magnetic resonance imaging in pharmacogenomics.

Authors:  Roberto Viviani; Marie-Louise Lehmann; Julia C Stingl
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

5.  Cognitive control network dysconnectivity and response to antipsychotic treatment in schizophrenia.

Authors:  Elyse J Cadena; David M White; Nina V Kraguljac; Meredith A Reid; Ripu Jindal; Roland Matthew Pixley; Adrienne C Lahti
Journal:  Schizophr Res       Date:  2018-08-08       Impact factor: 4.939

6.  Dopaminergic receptor blockade changes a functional connectivity network centred on the amygdala.

Authors:  Jan Haaker; Mareike M Menz; Tahmine Fadai; Falk Eippert; Christian Büchel
Journal:  Hum Brain Mapp       Date:  2016-11       Impact factor: 5.038

7.  Postprandial plasma PYY concentrations are associated with increased regional gray matter volume and rCBF declines in caudate nuclei--a combined MRI and H2(15)O PET study.

Authors:  Christopher M Weise; Pradeep Thiyyagura; Eric M Reiman; Kewei Chen; Jonathan Krakoff
Journal:  Neuroimage       Date:  2011-12-21       Impact factor: 6.556

Review 8.  Neuroimaging biomarkers for early drug development in schizophrenia.

Authors:  Jason R Tregellas
Journal:  Biol Psychiatry       Date:  2013-10-04       Impact factor: 13.382

9.  Metabolic Abnormalities in the Hippocampus of Patients with Schizophrenia: A 3D Multivoxel MR Spectroscopic Imaging Study at 3T.

Authors:  E J Meyer; I I Kirov; A Tal; M S Davitz; J S Babb; M Lazar; D Malaspina; O Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-21       Impact factor: 3.825

10.  Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia.

Authors:  Adrienne C Lahti; Martin A Weiler; Henry H Holcomb; Carol A Tamminga; Karen L Cropsey
Journal:  Neuropsychopharmacology       Date:  2009-08-12       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.